Mizuho Securities USA LLC Purchases 3,700 Shares of The Clorox Company (NYSE:CLX)

Mizuho Securities USA LLC grew its position in shares of The Clorox Company (NYSE:CLX) by 46.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,732 shares of the company’s stock after buying an additional 3,700 shares during the quarter. Mizuho Securities USA LLC’s holdings in Clorox were worth $1,905,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Integral Investment Advisors Inc. lifted its holdings in Clorox by 4.1% during the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares during the period. HCR Wealth Advisors increased its position in shares of Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after purchasing an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC raised its stake in shares of Clorox by 6.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock worth $218,000 after purchasing an additional 77 shares during the period. Brooklyn Investment Group boosted its holdings in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the last quarter. Finally, Global X Japan Co. Ltd. grew its position in Clorox by 3.0% during the fourth quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company’s stock valued at $531,000 after buying an additional 95 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $143.75 on Tuesday. The firm has a 50 day moving average of $152.57 and a 200-day moving average of $159.59. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The firm has a market capitalization of $17.71 billion, a P/E ratio of 39.28, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business posted $2.16 earnings per share. As a group, sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.39%. Clorox’s payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research reports. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Wells Fargo & Company upped their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Finally, StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.